Newcells Biotech

About:

Newcells Biotech are experts in the production of induced pluripotent stem cells.

Website: http://newcellsbiotech.co.uk/

Top Investors: Northstar Ventures, Mercia Ventures, North East Innovation Fund, NVM Private Equity, Mercia Asset Management

Description:

Newcells Biotech are experts in the production of induced pluripotent stem cells (iPSCs) and their differentiation into a wide range of reliable and reproducible cell and tissue types. Their focus is to provide customers engaged in drug discovery, pre-clinical development and disease mechanism investigation, with the best quality cells and services.

Total Funding Amount:

14.5M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom

Founded Date:

2015-01-01

Founders:

Lyle Armstrong, Majlinda Lako, Mike Nicholds

Number of Employees:

1-10

Last Funding Date:

2024-02-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai